Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Sawgrass Asset Management - Large Cap Quality Growth. This analysis is provided for institutional research purposes only and is not investment advice.
"The Sawgrass Large Cap Quality Growth portfolio returned 3.2% in Q4, outperforming the benchmark by 2.1% due to strong health care rotation and non-Mag7 tech stock gains, despite headwinds from software and defensive positions. Looking into 2026, the fund is positioned to benefit from an expected market transition toward fundamental earnings strength over momentum."
In 4Q25, the growth market gained 1.1% amid concerns over the Fed, economic stability, and the return on massive AI spending. The Sawgrass Large Cap Quality Growth portfolio outperformed, returning 3.2% (beating the Russell 1000 Growth Index by 2.1%). Strong contributors included non-Mag7 tech stocks (AMD, Applied Materials) and healthcare picks (Eli Lilly, United Therapeutics, Danaher) as market rotation broadened. Conversely, performance was hampered by weakness in defensive stocks (AutoZone, Comcast, Zoetis) and software names (ServiceNow, Workday) impacted by fears of AI-driven threat to subscription models. Looking forward, with the S&P 500 trading at an elevated forward P/E of 22.1, the manager expects a shift in 2026 towards fundamental earnings delivery and balance-sheet strength, which should benefit the fund's quality-focused positioning.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: The Sawgrass Large Cap Quality Growth portfolio returned 3.2% in Q4, outperforming the benchmark by 2.1% due to strong health care rotation and non-Mag7 tech stock gains, despite h...
Growth Outlook
Market outlook remains above average conviction: The Sawgrass Large Cap Quality Growth portfolio returned 3.2% in Q4, outperforming the benchmark by 2.1% due to strong health care rotation and non-Mag7 tech stock gains, despite h...
Risk Appetite
Risk appetite posture is moderate conviction: The Sawgrass Large Cap Quality Growth portfolio returned 3.2% in Q4, outperforming the benchmark by 2.1% due to strong health care rotation and non-Mag7 tech stock gains, despite h...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. The Sawgrass Large Cap Quality Growth portfolio returned 3.2% in Q4, outperforming the benchmark by 2.1% due to strong health care rotation and non-Mag7 tech stock gains, despite h...
Forward Guidance
Forward guidance signal: The Sawgrass Large Cap Quality Growth portfolio returned 3.2% in Q4, outperforming the benchmark by 2.1% due to strong health care rotation and non-Mag7 tech stock gains, despite h...
Language Signal
Tone analysis indicates above average conviction language: The Sawgrass Large Cap Quality Growth portfolio returned 3.2% in Q4, outperforming the benchmark by 2.1% due to strong health care rotation and non-Mag7 tech stock gains, despite h...
Perceived Risk
Perceived risk level is evaluated as above average conviction. The Sawgrass Large Cap Quality Growth portfolio returned 3.2% in Q4, outperforming the benchmark by 2.1% due to strong health care rotation and non-Mag7 tech stock gains, despite h...
Opportunity Density
Opportunity density index indicates above average conviction actionable entry points. The Sawgrass Large Cap Quality Growth portfolio returned 3.2% in Q4, outperforming the benchmark by 2.1% due to strong health care rotation and non-Mag7 tech stock gains, despite h...
Time Horizon
Investment time horizon reflects a high conviction orientation. The Sawgrass Large Cap Quality Growth portfolio returned 3.2% in Q4, outperforming the benchmark by 2.1% due to strong health care rotation and non-Mag7 tech stock gains, despite h...
